Additional data: Tumors, solid cancers

[Guest guest]

This is from the GEIPE website. Search GEIPE on google.com for more

information. It is not a germkilling application, so we don't have

a lot to say about it, not yet.

But it is not that different from what we are doing. The technique

is similar to inactivating spider or snake venom with a mild

electric current. See our files for outcomes with that. In South

America, they use this commonly to disable certain venoms, and it's

quite effective. Also a lot easier and less painful than bleeding

the person.

This is an interesting read. It's not held out as a " cure "

or " treatment " in the usual sense. No research funding yet, so no

studies were done. I think it shows merit based on already

established science, and not too far-fetched to be plausible.

bG

Enzymes control what takes place in a cell. The pivotal enzyme for

the synthesis of DNA, and thus for cell growth, is RR

(ribonucleotide reductase) since it supplies building blocks of DNA.

Table-1 shows how critical is this enzyme for the growth of

cancerous cells. Attempts are continuously being made to synthesize

chemotherapeutic drugs that would selectively inhibit this enzyme,

but with little success.

A novel way of blocking this enzyme is suggested by the fact that at

the gcoreh (active-site) of this enzyme is a lone electron (free-

radical) which is essential for its activity. Such free radicals can

be neutralized or disabled by passing mild direct electric current

through the tissue. Since the concentration of the target enzyme RR

is much higher in cancerous cells, as compared to healthy resting

cells, the gentle DC electrotherapy would act selectively on

malignant growth.

The connection between low & #8209;level DC electrotherapy and deactivation

of enzyme RR is a recent proposal. However, use of low & #8209;level

direct electric currents to treat tumor -- without any clear

understanding of the underlying mechanism & #8209; & #8209; have been reported in

scientific literature at least ten times during the last 50 years.

Results of all these studies are consistent with the proposed

deactivation of the pivotal enzyme.

Outcome reported in three of these papers were very encouraging. For

example, a study published in the prominent journal Cancer Research

in 1985 reported 98% reduction in the tumor mass of lab animals -- a

virtual cure. Please see Table-2.

Note: On contacting the head scientist Dr. Herbert of the 1985

study, it was discovered that he was denied funding to study the

procedure further. Please see his letter in 'Testimonials &

Correspondences'.

œœœ

Note: GEIPE cancer therapy is likely to be effective in treating

various solid cancers such as bladder, bone, brain, breast,

cervical, colon, esophageal, kidney, liver, lung, ovarian,

pancreatic, prostate, rectal, skin, stomach, testicular, throat &

uterine cancers.